1
|
Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.
|
J Cell Biol
|
2002
|
1.97
|
2
|
Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors.
|
J Clin Endocrinol Metab
|
2002
|
1.45
|
3
|
Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity.
|
Eur J Pharmacol
|
2002
|
1.24
|
4
|
The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects.
|
J Clin Endocrinol Metab
|
2003
|
1.12
|
5
|
Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines.
|
Eur J Endocrinol
|
2004
|
1.05
|
6
|
Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin.
|
Eur J Pharmacol
|
2003
|
0.98
|
7
|
The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells.
|
Endocrinology
|
2002
|
0.93
|
8
|
Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.
|
J Clin Endocrinol Metab
|
2002
|
0.88
|
9
|
New active series of growth hormone secretagogues.
|
J Med Chem
|
2003
|
0.87
|
10
|
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo.
|
Endocrinology
|
2002
|
0.87
|
11
|
Ghrelin injected into the paraventricular nucleus of the hypothalamus of male rats induces feeding but not penile erection.
|
Neurosci Lett
|
2002
|
0.87
|
12
|
The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.
|
Clin Endocrinol (Oxf)
|
2002
|
0.85
|
13
|
Ghrelin: much more than a natural growth hormone secretagogue.
|
Isr Med Assoc J
|
2002
|
0.83
|
14
|
PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.
|
Int J Pharm
|
2003
|
0.81
|
15
|
Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans.
|
J Clin Endocrinol Metab
|
2002
|
0.79
|
16
|
Ghrelin plays a minor role in the physiological control of cardiac function in the rat.
|
Endocrinology
|
2003
|
0.79
|
17
|
Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.
|
Clin Endocrinol (Oxf)
|
2002
|
0.78
|
18
|
Ghrelin and synthetic GH secretagogues.
|
Best Pract Res Clin Endocrinol Metab
|
2002
|
0.77
|
19
|
Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans.
|
Clin Endocrinol (Oxf)
|
2002
|
0.77
|
20
|
Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.
|
Clin Endocrinol (Oxf)
|
2003
|
0.77
|
21
|
Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery.
|
Eur J Pharmacol
|
2002
|
0.77
|
22
|
Ghrelin: endocrine and non-endocrine actions.
|
J Pediatr Endocrinol Metab
|
2002
|
0.76
|
23
|
Impact of two or three daily subcutaneous injections of hexarelin, a synthetic growth hormone (GH) secretagogue, on 24-h GH, prolactin, adrenocorticotropin and cortisol secretion in humans.
|
Eur J Endocrinol
|
2002
|
0.75
|
24
|
Growth hormone secretagogues: past, present and future.
|
IDrugs
|
2002
|
0.75
|
25
|
Ghrelin-induced GH secretion in normal subjects is partially resistant to homologous desensitization by GH-releasing peptide-6.
|
Eur J Endocrinol
|
2002
|
0.75
|
26
|
Activation of GABAA and opioid receptors reduce penile erection induced by hexarelin peptides.
|
Pharmacol Biochem Behav
|
2003
|
0.75
|
27
|
Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses.
|
Neuroendocrinology
|
2002
|
0.75
|